These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22648504)

  • 61. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
    Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.
    Guindalini RS; Song A; Fackenthal JD; Olopade OI; Huo D
    Cancer; 2016 Jun; 122(12):1913-20. PubMed ID: 26992017
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.
    Lorenzo Bermejo J; Hemminki K
    Ann Oncol; 2004 Dec; 15(12):1834-41. PubMed ID: 15550590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Breast cancer in monozygotic twins].
    Hladíková A; Plevová P; Macháčková E
    Klin Onkol; 2013; 26(3):213-7. PubMed ID: 23763326
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Psychosocial stress and breast-cancer risk].
    Wenderlein JM
    Med Welt; 1978 Dec; 29(49):1911-4. PubMed ID: 732562
    [No Abstract]   [Full Text] [Related]  

  • 68. Breast cancer susceptibility and the DNA damage response.
    Dapic V; Carvalho MA; Monteiro AN
    Cancer Control; 2005 Apr; 12(2):127-36. PubMed ID: 15855896
    [No Abstract]   [Full Text] [Related]  

  • 69. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations.
    Esplen MJ; Hunter J; Leszcz M; Warner E; Narod S; Metcalfe K; Glendon G; Butler K; Liede A; Young MA; Kieffer S; DiProspero L; Irwin E; Wong J
    Cancer; 2004 Nov; 101(10):2327-40. PubMed ID: 15478194
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Function of BRCA1 and BRCA2 genes associated with hereditary predisposition to breast cancer].
    Jasińska A; Krzyzosiak WJ
    Postepy Biochem; 2001; 47(2):146-59. PubMed ID: 11757317
    [No Abstract]   [Full Text] [Related]  

  • 71. Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation.
    Aretini P; D'Andrea E; Pasini B; Viel A; Mariani Costantini R; Cortesi L; Ricevuto E; Agata S; Bisegna R; Boiocchi M; Caligo MA; Chieco-Bianchi L; Cipollini G; Crucianelli R; D'Amico C; Federico M; Ghimenti C; De Giacomi C; De Nicolo A; Della Puppa L; Ferrari S; Ficorella C; Iandolo D; Manoukian S; Marchetti P; Marroni F; Menin C; Montagna M; Ottini L; Pensotti V; Pierotti M; Radice P; Santarosa M; Silingardi V; Turchetti D; Bevilacqua G; Presciuttini S
    Breast Cancer Res Treat; 2003 Sep; 81(1):71-9. PubMed ID: 14531499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Schwartz MD; Wenzel L; Narod S; Peshkin BN; Cella D; Lerman C
    J Behav Med; 2004 Aug; 27(4):373-92. PubMed ID: 15559734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
    Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
    Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.
    Pietschmann A; Mehdipour P; Mehdipour P; Atri M; Hofmann W; Hosseini-Asl SS; Scherneck S; Mundlos S; Peters H
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):552-8. PubMed ID: 15918047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
    Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
    J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    Sung PL; Wen KC; Chen YJ; Chao TC; Tsai YF; Tseng LM; Qiu JT; Chao KC; Wu HH; Chuang CM; Wang PH; Huang CF
    PLoS One; 2017; 12(9):e0185615. PubMed ID: 28961279
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes.
    Caldes T; de la Hoya M; Tosar A; Sulleiro S; Godino J; Ibañez D; Martin M; Perez-Segura P; Diaz-Rubio E
    J Med Genet; 2002 Aug; 39(8):e44. PubMed ID: 12161611
    [No Abstract]   [Full Text] [Related]  

  • 78. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Perception accuracy of BRCA1/2 mutation predisposition in breast cancer women and associated factors].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa-Lyonnet D; Sultan S
    Bull Cancer; 2012 Jun; 99(6):673-84. PubMed ID: 22641341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
    Bisgin A; Boga I; Yalav O; Sonmezler O; Tug Bozdogan S
    Breast J; 2019 Sep; 25(5):1029-1033. PubMed ID: 31228304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.